A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
复制标题

全血检测用于测量COVID-19患者的SARS-CoV-2特异性反应。

DOI:
10.1016/j.cmi.2020.09.051
复制
发表时间:
2021-03
期刊:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子:
--
通讯作者:
Goletti D
Goletti D
中科院分区:
其他
文献类型:
--
作者:
Petrone L;Petruccioli E;Vanini V;Cuzzi G;Najafi Fard S;Alonzi T;Castilletti C;Palmieri F;Gualano G;Vittozzi P;Nicastri E;Lepore L;Antinori A;Vergori A;Caccamo N;Cantini F;Girardi E;Ippolito G;Grifoni A;Goletti D

文献摘要

参考文献

被引文献

相似文献

研究是否可以使用全血实验环境在COVID-19中检测到对SARS-CoV-2肽的特异性T细胞应答,这可能进一步探索作为潜在的诊断工具。我们评估了用来自SARS-CoV-2序列的刺突抗原和抗原肽巨库(MP)刺激全血后的干扰素(IFN)-γ水平;白细胞介素(IL)-1β、IL-1 RA、IL-2、IL-4、IL-5、IL-6、IL-7、IL-8、IL-9、IL-10、IL-12 p70、IL-13、IL-15、IL-17 A、嗜酸性粒细胞趋化因子、碱性成纤维细胞生长因子(FGF),粒细胞集落刺激因子(G-CSF)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、IFN-γ、干扰素γ诱导蛋白10(IP-10)、单核细胞趋化蛋白-1(MCP-1)、巨噬细胞炎性蛋白(MIP)-1α、MIP-1β、血小板衍生生长因子(PDGF)、RANTES(调节活化、正常T细胞表达和分泌)、肿瘤坏死因子-α(TNF-α)、血管内皮生长因子(VEGF)也进行了评价。与29名“非COVID-19”个体相比,35名COVID-19患者对棘突和增殖抗原MP的IFN-γ应答显著增加(中位棘突-MP:0.26 vs 0,p = 0.0002;中位增殖抗原-MP:0.07 vs 0.02; p = 0.02)。这种反应的检测与患者的临床参数无关。与“非COVID-19”个体相比,COVID-19个体对SARS-CoV-2无关抗原巨细胞病毒(CMV)和葡萄球菌肠毒素B(SE B)的IFN-γ反应相似(CMV中位数:3.46 vs 5.28,p = 0.16; SE B中位数:12.68 vs 15.05; p = 0.1)。在对COVID-19中的峰值MP的反应中-与“无COVID-19”的个体相比,我们发现IL-2的中位数显著更高,(50.08对0,p = 0.0018)、IFN-γ(90.16对0,p = 0.01)、IL-4(0.52对0,p = 0.03)、IL-13(0.84对0,p = 0.007)和MCP-1(4602对359.2,p = 0.05)。在全血测定中对SARS-CoV-2肽的免疫应答与COVID-19相关,其特征在于Th 1和Th 2谱。这种实验方法可能有助于开发新的基于T细胞的疾病和疫苗设置的诊断测试。
To examine whether specific T-cell-responses to SARS-CoV-2 peptides can be detected in COVID-19 using a whole-blood experimental setting, which may be further explored as a potential diagnostic tool. We evaluated interferon (IFN)-γ levels after stimulating whole-blood with spike and remainder-antigens peptides megapools (MP) derived from SARS-CoV-2 sequences; interleukin (IL)-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12p70, IL-13, IL-15, IL-17A, eotaxin, basic fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), IFN-γ, Interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α, MIP-1β, Platelet-derived growth factor (PDGF), RANTES (regulated on activation, normal T cell expressed and secreted), tumour necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF) were also evaluated. IFN-γ-response to spike and remainder-antigens MPs was significantly increased in 35 COVID-19 patients compared with 29 ‘no COVID-19’ individuals (medians spike-MP: 0.26 vs 0, p = 0.0002; medians remainder-antigens-MP: 0.07 vs 0.02; p = 0.02). This response was detected independently of patients' clinical parameters. IFN-γ-response to SARS-CoV-2-unrelated antigens cytomegalovirus (CMV) and Staphylococcal Enterotoxin B (SEB) was similar in COVID-19 compared with ‘no COVID-19’ individuals (median CMV: 3.46 vs 5.28, p = 0.16; median SEB: 12.68 vs 15.05; p = 0.1). In response to spike-MPs in COVID-19- compared with ‘no COVID-19’ -individuals, we found significant higher median of IL-2 (50.08 vs 0, p = 0.0018), IFN-γ (90.16 vs 0, p = 0.01), IL-4 (0.52 vs 0, p = 0.03), IL-13 (0.84 vs 0, p = 0.007) and MCP-1 (4602 vs 359.2, p = 0.05). Immune response to SARS-CoV-2 peptides in a whole-blood assay is associated with COVID-19 and it is characterized by both Th1 and Th2 profile. This experimental approach may be useful for developing new T-cell based diagnostic tests for disease and vaccine settings.
DOI: 10.1093/cid/ciaa577
发表时间: 2020-10-15
影响因子: 11.8
作者:
Bordoni, Veronica;Sacchi, Alessandra;Agrati, Chiara
通讯作者: Agrati, Chiara
DOI: 10.1371/journal.pone.0183846
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者:
Chiacchio T;Delogu G;Vanini V;Cuzzi G;De Maio F;Pinnetti C;Sampaolesi A;Antinori A;Goletti D
通讯作者: Goletti D
DOI: 10.1155/2015/763461
发表时间: 2015-01-01
影响因子: 4.1
作者:
Carrasco Pro, Sebastian;Sidney, John;Sette, Alessandro
通讯作者: Sette, Alessandro
DOI: 10.4081/idr.2020.8543
发表时间: 2020-01-01
影响因子: 3.2
作者:
Nicastri, Emanuele;Petrosillo, Nicola;Antinori, Andrea
通讯作者: Antinori, Andrea
DOI: 10.1128/cdli.12.11.1311-1316.2005
发表时间: 2005-11-01
期刊: CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
影响因子: --
作者:
Goletti, D;Vincenti, D;Girardi, E
通讯作者: Girardi, E